Adalimumab/infliximab/thalidomideDevelopment of antibodies to drug and neuropathy: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2018年 / 1727卷 / 1期
关键词：
D O I：
10.1007/s40278-018-54003-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：18 / 18
相关论文
共 50 条
  • [41] Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab
    Yanai, Henit
    Lichtenstein, Lev
    Assa, Amit
    Mazor, Yoav
    Weiss, Batia
    Levine, Arie
    Ron, Yulia
    Kopylov, Uri
    Bujanover, Yoram
    Rosenbach, Yoram
    Ungar, Bella
    Eliakim, Rami
    Chowers, Yehuda
    Shamir, Raanan
    Fraser, Gerald
    Dotan, Iris
    Ben-Horin, Shomron
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (03) : 522 - 530
  • [42] Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab
    Gorovits, B.
    Baltrukonis, D. J.
    Bhattacharya, I
    Birchler, M. A.
    Finco, D.
    Sikkema, D.
    Vincent, M. S.
    Lula, S.
    Marshall, L.
    Hickling, T. P.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 192 (03): : 348 - 365
  • [43] Infliximab/VedolizumabLack of efficacy and development of anti-infliximab-antibodies : case report
    Reactions Weekly, 2024, 2037 (1) : 214 - 214
  • [44] Influence of neutralizing antibodies to adalimumab and infliximab on the treatment of psoriasis
    Bito, T.
    Nishikawa, R.
    Hatakeyama, M.
    Kikusawa, A.
    Kanki, H.
    Nagai, H.
    Sarayama, Y.
    Ikeda, T.
    Yoshizaki, H.
    Seto, H.
    Adachi, A.
    Horikawa, T.
    Oka, M.
    Nishigori, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (04) : 922 - 929
  • [45] Adalimumab/etanercept/infliximabBronchospasm (first report with etanercept and infliximab): 5 case reports
    Reactions Weekly, 2006, 1110 (1) : 4 - 4
  • [46] Adalimumab/infliximab/vedolizumabAnaphylaxis and fatal Creutzfeldt-Jakob disease: case report
    Reactions Weekly, 2019, 1776 (1) : 20 - 20
  • [47] Adalimumab/golimumab/infliximabCytomegalovirus infection, development of anti-drug antibodies and lack of efficacy: case report
    Reactions Weekly, 2021, 1885 (1) : 28 - 28
  • [48] Adalimumab/infliximab/mesalazineDrug-induced liver injury and no response: case report
    Reactions Weekly, 2021, 1860 (1) : 22 - 22
  • [49] Adalimumab/infliximab/ustekinumabCutaneous focal mucinosis in an elderly patient with psoriasis: case report
    Reactions Weekly, 2015, 1533 (1) : 25 - 25
  • [50] Adalimumab/infliximab/ustekinumabCutaneous focal mucinosis in an elderly patient with psoriasis: case report
    Reactions Weekly, 2013, 1443 (1) : 5 - 5
12345